# Metabolomic Exploration of Dysregulated Lipid Metabolism in MFN2-related CMT2A (MetaDLM_CMT2A)

> **NCT04881201** · NA · COMPLETED · sponsor: **University Hospital, Angers** · enrollment: 47 (actual)

## Conditions studied

- Charcot-Marie-Tooth Disease Type 2A

## Interventions

- **PROCEDURE:** blood sample

## Key facts

- **NCT ID:** NCT04881201
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-05
- **Primary completion:** 2024-06-10
- **Final completion:** 2024-06-10
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2024-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04881201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04881201, "Metabolomic Exploration of Dysregulated Lipid Metabolism in MFN2-related CMT2A (MetaDLM_CMT2A)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04881201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*